40 results
8-K
EX-99.1
STRO
Sutro Biopharma Inc
2 Apr 24
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
6:04am
Chung, President and Chief Operating Officer at Sutro. “Sutro’s research innovation represented in STRO-003 illustrates our leadership in ADC design … innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40
8-K
EX-99.1
STRO
Sutro Biopharma Inc
25 Mar 24
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
-value collaborations and industry partnerships, validates Sutro’s continuous product innovation. Sutro is headquartered in South San Francisco
8-K
EX-99.1
STRO
Sutro Biopharma Inc
8 Jan 24
Results of Operations and Financial Condition
7:31am
–A Pipeline in a Drug (Luvelta, STRO-002)
Luvelta: Exemplifies Sutro’s Innovation in ADC Development Cell-free XpressCF®Proven Technology … and durability of response ADC innovation leader * Based on the estimated value of cash, cash equivalents and marketable securities
8-K
EX-99.1
d3e20z b65f
21 Nov 23
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.1
wvkmzeh 0bxli
13 Nov 23
Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
PRE 14A
eikmcixy8esem6w2e3w
14 Apr 23
Preliminary proxy
4:05pm